Novo Nordisk (NYSE: NVO) Stock Dips as Rivalry Heats Up: Lilly Drug Outperforms in Weight Loss Study
LONDON – Shares in Novo Nordisk (NYSE: NVO), maker of the wildly popular obesity drug Wegovy, were down 1.1% on […]
Latest News on Novo Nordisk A/S (NVO) Stock
UK Regulators Reprimand Novo Nordisk (NYSE: NVO) for Non-Disclosure of Healthcare Sector Payments
COPENHAGEN – UK regulators reprimanded Danish drugmaker Novo Nordisk (NYSE: NVO) for failing to disclose fees and expenses paid to
